Aspirin doubles survival chances of patients with gastro-intestinal cancer
The results from a Dutch cohort study with 13,715 gastro-intestinal (GI) cancer patients show that the use of aspirin after diagnosis increases the five-year survival rate from 42 to 75 percent. Martine Frouws, research physician at the Leiden University Medical Centre, presented her findings at the European Cancer Congress (ECC) in Vienna on the 28th of September 2015. Continue reading